Brian Huber

home / authors / brian-huber

Brian Huber is vice-president of Therapeutic Areas, Drug Development, and Consulting at ICON.

Articles

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d rendering | Image Credit: © Design Cells - © Design Cells - stock.adobe.com

Difficulties in Expanding CAR-T Cell Therapy into Solid Tumors

Brian Huber;Tamie Joeckel

There are various challenges associated with the development of CAR-T therapies for solid tumor cancers.

T-Cells Work to Fight Cancer, Immunotherapy, CAR T-cell therapy, 3d rendering | Image Credit: © Design Cells - © Design Cells - stock.adobe.com

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

Brian Huber;Tamie Joeckel

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: December 9th 2024 | Updated: December 22nd 2024

Recap Key Industry Trends for Viral Clearance and NGS

Shining Pro - Stock.Adobe.com

Published: December 7th 2024 | Updated: December 22nd 2024

Enhancing Quality Through Training

Published: July 20th 2020 | Updated: December 22nd 2024

Contact BioPharm International Editors

Published: July 19th 2020 | Updated: December 22nd 2024

Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.